Viemed Healthcare, Inc. (NASDAQ:VMD - Get Free Report) was the target of a significant drop in short interest in the month of April. As of April 15th, there was short interest totalling 340,000 shares, a drop of 14.6% from the March 31st total of 398,300 shares. Based on an average trading volume of 112,600 shares, the days-to-cover ratio is currently 3.0 days. Approximately 1.0% of the shares of the stock are short sold.
Hedge Funds Weigh In On Viemed Healthcare
Institutional investors and hedge funds have recently modified their holdings of the business. Divisadero Street Capital Management LP grew its stake in shares of Viemed Healthcare by 84.8% during the 4th quarter. Divisadero Street Capital Management LP now owns 646,273 shares of the company's stock valued at $5,183,000 after acquiring an additional 296,481 shares during the period. Rice Hall James & Associates LLC acquired a new stake in Viemed Healthcare in the fourth quarter valued at approximately $2,083,000. First Eagle Investment Management LLC lifted its position in Viemed Healthcare by 196.5% during the 4th quarter. First Eagle Investment Management LLC now owns 328,824 shares of the company's stock worth $2,637,000 after acquiring an additional 217,923 shares during the period. Arrowstreet Capital Limited Partnership purchased a new stake in Viemed Healthcare in the 4th quarter worth approximately $1,549,000. Finally, Expect Equity LLC purchased a new position in Viemed Healthcare during the fourth quarter valued at $1,369,000. 74.24% of the stock is currently owned by institutional investors.
Viemed Healthcare Stock Down 8.9 %
NASDAQ:VMD traded down $0.65 on Thursday, hitting $6.62. 108,176 shares of the company's stock traded hands, compared to its average volume of 139,863. The company has a current ratio of 1.31, a quick ratio of 1.19 and a debt-to-equity ratio of 0.03. Viemed Healthcare has a 1 year low of $6.21 and a 1 year high of $9.81. The firm has a 50-day moving average price of $7.12 and a 200-day moving average price of $7.96. The company has a market cap of $261.69 million, a PE ratio of 24.83 and a beta of 1.49.
Viemed Healthcare (NASDAQ:VMD - Get Free Report) last announced its quarterly earnings data on Wednesday, May 7th. The company reported $0.06 earnings per share for the quarter, meeting the consensus estimate of $0.06. The business had revenue of $59.10 million for the quarter, compared to analyst estimates of $60.60 million. Viemed Healthcare had a net margin of 4.87% and a return on equity of 8.72%.
About Viemed Healthcare
(
Get Free Report)
Viemed Healthcare, Inc, together with its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD.
Read More
Before you consider Viemed Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Viemed Healthcare wasn't on the list.
While Viemed Healthcare currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.
Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.